What Are the Challenges in Targeting Protein Degradation in Cancer?
While targeting protein degradation presents a novel therapeutic avenue, there are challenges. Cancer cells can develop resistance to drugs targeting these pathways. Additionally, the systemic inhibition of protein degradation can have widespread effects due to the integral role of these pathways in normal cellular function. Therefore, specificity and minimizing off-target effects are critical considerations in the development of such therapies.
